We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USFD:NYSEUS Foods Holding Corp. Analysis

Data as of 2026-08-01 - not real-time

$100.59

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

US Foods is trading at $100.59, comfortably above its 20‑day SMA of $99.29 and well above the 50‑day ($93.56) and 200‑day ($86.25) averages, indicating a bullish price trend. The RSI of 57 suggests modest momentum without being overbought. However, the MACD histogram has turned negative and the MACD signal is labeled “bearish,” hinting at a possible short‑term softening. Volume has been decreasing, which could limit upside on any further rally. The stock’s beta of 0.21 points to low systematic risk, while 30‑day volatility sits near 30%, a relatively high level for a consumer‑defensive name.
Fundamentally, US Foods posted 2.8% revenue growth YoY and a forward EPS of $5.48, yet margins remain thin (gross 17.4%, operating 2.3%) and debt‑to‑equity is an alarming 123, reflecting a heavily leveraged balance sheet. The DCF‑derived fair value of $24.86 is dramatically below the current price, yielding an upside/downside estimate of only +5% and flagging the stock as overvalued. The PE of 33.9 versus a forward PE of 18.4 underscores the market’s premium pricing for expected growth, but the lack of any dividend further limits total return. Recent news cites new long‑term contracts with the U.S. Navy and market‑share gains in the independent restaurant segment, which could support earnings momentum. Nonetheless, the combination of high leverage, thin profitability and a valuation gap suggests investors should be cautious, especially on a longer horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above all major SMAs indicating bullish trend
  • Bearish MACD histogram and decreasing volume
  • Low beta but elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Modest revenue growth and new Navy contracts
  • High debt‑to‑equity ratio limiting financial flexibility
  • Overvaluation relative to DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value far below market price
  • Thin profit margins and heavy leverage
  • Lack of dividend and limited upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin1.71%
P/E Ratio33.9
ROE15.13%
ROA5.59%
Debt/Equity122.89
P/B Ratio5.1
Op. Cash Flow$1.3B
Free Cash Flow$743.5M

Technical Analysis

TrendBullish
RSI57.4
Support$93.14
Resistance$105.17
MA 20$99.29
MA 50$93.56
MA 200$86.25
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$24.86
Target Price$105.75
Upside/Downside5.13%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.22
Volatility30.12%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.